Reports Q4 revenue $258.4M, consensus $250.1M. “Our strong finish to 2024 was driven by excellent performance in Sealing Technologies and ...

In a report released today, James Gordon from J.P. Morgan maintained a Buy rating on AstraZeneca (AZN – Research Report), with a price target ...

Astrazeneca has defended the £14.7 million pay package handed to chief executive Pascal Soriot, saying the group is too big ...

AT&T Inc. Dep. Pfd. (Rep. 1/1000th 4.75% Pfd. Series C)-0.51% AT&T Inc. Dep. Pfd. (Rep. 1/1000th 5% Perp. Pfd. Series A)-0.14% ...